Valuation: Vitrolife AB

Market Cap 11.66B 1.22B 1.06B 989M 908M 1.72B 117B 1.74B 4.58B 58.1B 4.59B 4.49B 195B P/E 2026 *
23.7x
P/E 2027 * 19.1x
Enterprise Value 12.21B 1.28B 1.11B 1.04B 951M 1.8B 122B 1.82B 4.79B 60.84B 4.81B 4.7B 204B EV / Sales 2026 *
3.53x
EV / Sales 2027 * 3.14x
Free-Float
54.39%
Yield 2026 *
1.28%
Yield 2027 * 1.46%
1 day-0.29%
1 week+1.06%
1 month-1.88%
3 months-17.77%
6 months-25.90%
Current year-37.15%
1 week 84
Extreme 84
88.2
1 month 84
Extreme 84
101.9
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
153.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 01/08/2023
Director of Finance/CFO 55 10/10/2025
Chief Investment Officer 40 -
Director TitleAgeSince
Director/Board Member 63 19/04/2013
Chairman 70 01/08/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap.
2/6/26 A Buy

Chief Operating Officer

6,470 0.0048%
2/6/26 A Buy

Chief Executive Officer

3,013 0.0022%
2/4/26 A Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-0.29%+1.06%-40.21%-44.88% 1.22B
+6.33%+9.95%+295.29%+315.15% 21.74B
-3.83%-1.14%-45.07%-29.17% 9.38B
-1.35%-4.94%+39.96%+15.20% 6.49B
-4.37%+2.16%+251.45%-24.94% 6B
-1.81%-0.93%-13.78%-15.42% 5.57B
-2.61%+0.97%-44.20% - 4.43B
+4.21%+7.67%-16.15%-29.58% 4.38B
+9.99%+1.30%+75.99%+91.71% 4.25B
-1.02%+5.24%-16.77%-40.86% 2.8B
Average +0.52%+1.60%+48.65%+26.35% 6.63B
Weighted average by Cap. +1.55%+3.38%+115.44%+105.64%

Financials

2026 *2027 *
Net sales 3.46B 363M 315M 293M 269M 509M 34.61B 516M 1.36B 17.23B 1.36B 1.33B 57.77B 3.71B 389M 338M 315M 289M 545M 37.1B 554M 1.45B 18.47B 1.46B 1.43B 61.94B
Net income 493M 51.64M 44.89M 41.78M 38.36M 72.44M 4.93B 73.57M 193M 2.45B 194M 190M 8.23B 609M 63.83M 55.48M 51.64M 47.41M 89.54M 6.09B 90.93M 239M 3.03B 240M 234M 10.17B
Net Debt 549M 57.57M 50.04M 46.58M 42.76M 80.76M 5.5B 82.01M 215M 2.74B 216M 211M 9.17B -26.74M -2.8M -2.44M -2.27M -2.08M -3.93M -268M -3.99M -10.49M -133M -10.53M -10.3M -447M
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
31/07/26 SEK 86.10 -0.29% 120,557
30/07/26 SEK 86.35 -0.75% 172,895
29/07/26 SEK 87.00 +0.58% 245,976
28/07/26 SEK 86.50 +1.17% 183,084
27/07/26 SEK 85.50 +0.35% 120,468
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
86.10SEK
Average target price
129.60SEK
Spread / Average Target
+50.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock